Stories by Amy Maxmen

Critics push back on proposed CDC guidelines that they say leave health care facilities free to cut corners on N95 masks and other measures that protect workers against airborne diseases such as COVID

In South Africa, a network of researchers are studying whether new lineages BA.4 and BA.5 escape immunity from COVID-19 vaccines and prior infections

The reports’ authors say that the novel coronavirus, or SARS-CoV-2, jumped from animals sold at the market to people twice in late 2019—but some scientists want more definitive evidence

Celebrated sociologist Alondra Nelson and genome leader Francis Collins will temporarily split Lander’s duties

Studies suggest that a reversal of the landmark Roe v. Wade decision would be detrimental for many

The WHO-approved RTS,S vaccine has a modest efficacy and requires a complex regimen of doses, so ample funding and clear communication are crucial to success

An examination of the arguments that SARS-CoV-2 escaped from a lab in China and the science behind them

Allegations that COVID escaped from a Chinese lab make it harder for nations to collaborate on ending the pandemic—and fuel online bullying—some scientists say

In California’s San Joaquin Valley, some researchers are turning political to address the social determinants of health

The development from the Biden administration draws cheers from public health researchers and ire from drugmakers

Scientists say the conclusions make sense but note that supporters of the lab-leak theory are unlikely to be satisfied

Biden health official Rachel Levine has a strong track record of fighting for social justice in health care, researchers say

Open repository will give free access to more than 160 million data points with details about individual infections

The coronavirus pandemic, climate change and space exploration are among the issues that Biden will influence if he wins the upcoming U.S. election

Political meddling, disorganization and years of neglect of public-health data management mean the country is flying blind

The scenarios foresaw leaky travel bans, a scramble for vaccines and disputes between state and federal leaders, but none could anticipate the current levels of dysfunction in the U.S.

The epidemic killed more than 2,000 people—but involved the first widespread use of a vaccine against the virus

As President Trump terminates the U.S.’s relationship with the agency, experts foresee incoherence, inefficiency and a resurgence of deadly diseases

An online survey reveals bottlenecks, challenges and barriers faced by more than 1,700 biology labs

The lack of a national strategy has stymied the efforts of academic labs that underwent huge efforts to retool for COVID-19 testing

New York City researchers hope antibody-rich plasma can keep people out of intensive care

The three-drug regimen cures 90 percent of people who have the deadliest form of the disease

People who receive either therapy soon after infection have a 90 percent survival rate, a clinical trial finds

Violence in the Democratic Republic of the Congo has interrupted clinical trials and forced scientists to change how they immunize people